Загрузка...
Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples
BACKGROUND: Monitoring hemophilia treatment with extended half‐life products is challenging for coagulation laboratories since factor assays may show substantial differences between results obtained with the one‐stage assay (OSA) and the chromogenic substrate assay (CSA). OBJECTIVES: The aim of this...
Сохранить в:
| Опубликовано в: : | Res Pract Thromb Haemost |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590307/ https://ncbi.nlm.nih.gov/pubmed/33134777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12421 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|